[Analysis of antibacterial activity of a new antiseptic for therapy of maxillofacial inflammations].
Clinical and experimental studies of polydimethyldiallylammonium chloride (PDMDAAC) experimentally validated the choice of optimal concentration and composition of this agent. The results indicate a high antiseptic activity of 1% PDMDAAC and the possibility of using it in local therapy of periodontitis and posttraumatic infection.